Davis Polk Guides Shire In $260M Liver Drug Maker Buy
Dublin-based drugmaker Shire PLC said Monday it had acquired private equity-backed Lumena Pharmaceuticals Inc. for more than $260 million in cash, taking on the San Diego-based company's rare diseases portfolio....To view the full article, register now.
Already a subscriber? Click here to view full article